Page last updated: 2024-08-22

butylhydroxybutylnitrosamine and Cancer of Ovary

butylhydroxybutylnitrosamine has been researched along with Cancer of Ovary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoyama, T; Ba, Y; Furuuchi, K; Hamada, J; Harada, H; Hirai, A; Hirai, K; Katsuoka, Y; Moriuchi, T; Nakata, D; Nishida, T; Shibahara, N; Tada, M; Tonoki, H; Yamamoto, K1

Other Studies

1 other study(ies) available for butylhydroxybutylnitrosamine and Cancer of Ovary

ArticleYear
A functional and quantitative mutational analysis of p53 mutations in yeast indicates strand biases and different roles of mutations in DMBA- and BBN-induced tumors in rats.
    International journal of cancer, 1999, Nov-26, Volume: 83, Issue:5

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Base Sequence; Butylhydroxybutylnitrosamine; Carcinogens; Color; False Positive Reactions; Female; Genes, p53; Male; Molecular Sequence Data; Mutagenicity Tests; Neoplasms, Experimental; Ovarian Neoplasms; Point Mutation; Rats; Rats, Inbred F344; Sensitivity and Specificity; Urinary Bladder Neoplasms; Yeasts

1999